BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14685255)

  • 1. Minichromosome maintenance protein in myxofibrosarcoma.
    Sington JD; Freeman A; Morris LS; Vowler SL; Arch BN; Fisher C; Coleman N
    Mod Pathol; 2004 Feb; 17(2):235-40. PubMed ID: 14685255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA replication licensing and cell cycle kinetics of normal and neoplastic breast.
    Shetty A; Loddo M; Fanshawe T; Prevost AT; Sainsbury R; Williams GH; Stoeber K
    Br J Cancer; 2005 Nov; 93(11):1295-300. PubMed ID: 16278669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis.
    Wharton SB; Chan KK; Anderson JR; Stoeber K; Williams GH
    Neuropathol Appl Neurobiol; 2001 Aug; 27(4):305-13. PubMed ID: 11532161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and clinical significance of the proliferation marker minichromosome maintenance protein 2 (Mcm2) in diffuse astrocytomas WHO grade II.
    Lind-Landström T; Varughese RK; Sundstrøm S; Torp SH
    Diagn Pathol; 2013 Apr; 8():67. PubMed ID: 23618321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle and apoptosis regulatory proteins, proliferative markers, cell signaling molecules, CD209, and decorin immunoreactivity in low-grade myxofibrosarcoma and myxoma.
    Cates JM; Memoli VA; Gonzalez RS
    Virchows Arch; 2015 Aug; 467(2):211-6. PubMed ID: 25940995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geminin, Ki67, and minichromosome maintenance 2 in gastric hyperplastic polyps, adenomas, and intestinal-type carcinomas: pathobiological significance.
    Shomori K; Nishihara K; Tamura T; Tatebe S; Horie Y; Nosaka K; Haruki T; Hamamoto Y; Shiomi T; Nakabayashi M; Ito H
    Gastric Cancer; 2010 Aug; 13(3):177-85. PubMed ID: 20820987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K; Cheale M; Coleman N; Fox SB
    Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma.
    Kato H; Miyazaki T; Fukai Y; Nakajima M; Sohda M; Takita J; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Asao T; Kuwano H
    J Surg Oncol; 2003 Sep; 84(1):24-30. PubMed ID: 12949987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model.
    Willems SM; Debiec-Rychter M; Szuhai K; Hogendoorn PC; Sciot R
    Mod Pathol; 2006 Mar; 19(3):407-16. PubMed ID: 16415793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer.
    Liu M; Li JS; Tian DP; Huang B; Rosqvist S; Su M
    Histol Histopathol; 2013 Apr; 28(4):481-92. PubMed ID: 23329420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance.
    Tokuyasu N; Shomori K; Nishihara K; Kawaguchi H; Fujioka S; Yamaga K; Ikeguchi M; Ito H
    Gastric Cancer; 2008; 11(1):37-46. PubMed ID: 18373176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of cell cycle state may facilitate the histopathological diagnosis of malignant mesothelioma.
    Sington JD; Morris LS; Nicholson AG; Coleman N
    Histopathology; 2003 May; 42(5):498-502. PubMed ID: 12713628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of cell cycle regulators in myxofibrosarcoma, with special emphasis on their prognostic implications.
    Oda Y; Takahira T; Kawaguchi K; Yamamoto H; Tamiya S; Matsuda S; Tanaka K; Kinukawa N; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2003 Oct; 34(10):1035-42. PubMed ID: 14608538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas.
    Torres-Rendon A; Roy S; Craig GT; Speight PM
    Br J Cancer; 2009 Apr; 100(7):1128-34. PubMed ID: 19293805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular high-grade myxofibrosarcoma of left buttock of 66-year-old male patient - approach to systematic histopathological reporting.
    Wincewicz A; Lewitowicz P; Matykiewicz J; Głuszek S; Sulkowski S
    Rom J Morphol Embryol; 2015; 56(4):1523-8. PubMed ID: 26743304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of GNAS mutations in intramuscular / cellular myxomas as diagnostic tool in the classification of myxoid soft tissue tumors.
    Sunitsch S; Gilg MM; Kashofer K; Gollowitsch F; Leithner A; Liegl-Atzwanger B
    Diagn Pathol; 2018 Aug; 13(1):52. PubMed ID: 30111377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix.
    Willems SM; Mohseny AB; Balog C; Sewrajsing R; Briaire-de Bruijn IH; Knijnenburg J; Cleton-Jansen AM; Sciot R; Fletcher CD; Deelder AM; Szuhai K; Hensbergen PJ; Hogendoorn PC
    J Cell Mol Med; 2009 Jul; 13(7):1291-301. PubMed ID: 19320777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early recurrence of benign meningioma correlates with expression of mini-chromosome maintenance-2 protein.
    Hunt DP; Freeman A; Morris LS; Burnet NG; Bird K; Davies TW; Laskey RA; Coleman N
    Br J Neurosurg; 2002 Feb; 16(1):10-5. PubMed ID: 11928726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoro-Chromogenic Labelling for Detection of MCM2 to Assess Proliferation Activity in HER2-amplified Breast Carcinomas.
    Luhtala S; Haapaniemi T; Staff S; Isola J
    Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):175-186. PubMed ID: 30358612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer.
    Gonzalez MA; Pinder SE; Callagy G; Vowler SL; Morris LS; Bird K; Bell JA; Laskey RA; Coleman N
    J Clin Oncol; 2003 Dec; 21(23):4306-13. PubMed ID: 14645419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.